Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 154

1.

MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes.

Ardin M, Cahais V, Castells X, Bouaoun L, Byrnes G, Herceg Z, Zavadil J, Olivier M.

BMC Bioinformatics. 2016 Apr 18;17:170. doi: 10.1186/s12859-016-1011-z.

2.

Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.

Riu M, Chiarello P, Terradas R, Sala M, Garcia-Alzorriz E, Castells X, Grau S, Cots F.

PLoS One. 2016 Apr 7;11(4):e0153076. doi: 10.1371/journal.pone.0153076. eCollection 2016.

3.

Clinical guideline for the treatment of dual pathology in the adult population.

San L, Arranz B, Dual Pathology Clinical Practice Guide EG, Arrojo M, Becoña E, Bernardo M, Caballero L, Castells X, Cunill R, Florez G, Franco MD, Garriga M, Goikolea JM, González-Pinto A, Landabaso M, López A, Martinez-Raga J, Merino A, Paramo M, Rubio G, Safont G, Saiz PA, Solà I, Tirado J, Torrens M, Zorrilla I.

Adicciones. 2016 Mar 2;28(1):3-5. doi: 10.20882/adicciones.784. English, Spanish.

4.

Risk of breast cancer after false-positive results in mammographic screening.

Román M, Castells X, Hofvind S, von Euler-Chelpin M.

Cancer Med. 2016 Feb 25. doi: 10.1002/cam4.646. [Epub ahead of print]

5.

Long-term costs of colorectal cancer treatment in Spain.

Corral J, Castells X, Molins E, Chiarello P, Borras JM, Cots F.

BMC Health Serv Res. 2016 Feb 16;16(1):56. doi: 10.1186/s12913-016-1297-6.

6.

Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.

Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M; BELE Study Group.

Radiology. 2016 Feb 15:151174. [Epub ahead of print]

PMID:
26878225
7.

Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular atrial fibrillation: phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database.

Giner-Soriano M, Vedia Urgell C, Roso-Llorach A, Morros R, Capellà D, Castells X, Ferreira-González I, Troncoso Mariño A, Diògene E, Elorza JM, Casajuana M, Bolíbar B, Violan C.

BMJ Open. 2016 Jan 28;6(1):e010144. doi: 10.1136/bmjopen-2015-010144.

8.

[Analysis of barriers and legal-ethical opportunities for disclosure and apology for medical errors in Spain].

Giraldo P, Corbella J, Rodrigo C, Comas M, Sala M, Castells X.

Gac Sanit. 2016 Mar-Apr;30(2):117-20. doi: 10.1016/j.gaceta.2015.11.007. Epub 2015 Dec 23. Spanish.

9.

A retrospective review of medical errors adjudicated in court between 2002 and 2012 in Spain.

Giraldo P, Sato L, Sala M, Comas M, Dywer K, Castells X.

Int J Qual Health Care. 2016 Feb;28(1):33-9. doi: 10.1093/intqhc/mzv089. Epub 2015 Nov 15.

PMID:
26573788
10.

[Economic impact of nosocomial bacteraemia. A comparison of three calculation methods].

Riu M, Chiarello P, Terradas R, Sala M, Castells X, Knobel H, Cots F.

Enferm Infecc Microbiol Clin. 2015 Nov 9. pii: S0213-005X(15)00344-4. doi: 10.1016/j.eimc.2015.09.007. [Epub ahead of print] Spanish.

PMID:
26564375
11.

Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.

Domingo L, Hofvind S, Hubbard RA, Román M, Benkeser D, Sala M, Castells X.

Eur Radiol. 2015 Nov 11. [Epub ahead of print]

PMID:
26560729
12.

Predicting Future Need Of Resources For Adenoma Surveillance From A Population-Based Colorectal Cancer Screening Program Through Discrete Event Simulation.

Comas M, Andreu M, Guerrero-Ludueña RE, Bessa X, Balagué F, Castells X.

Value Health. 2015 Nov;18(7):A465. doi: 10.1016/j.jval.2015.09.1217. Epub 2015 Oct 20. No abstract available.

PMID:
26532613
13.

Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.

Baré M, Torà N, Salas D, Sentís M, Ferrer J, Ibáñez J, Zubizarreta R, Sarriugarte G, Barata T, Domingo L, Castells X, Sala M.

Breast Cancer Res Treat. 2015 Nov;154(2):403-15. doi: 10.1007/s10549-015-3623-9. Epub 2015 Nov 3.

PMID:
26531756
14.

Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.

Cunill R, Castells X, Tobias A, Capellà D.

Psychopharmacology (Berl). 2016 Jan;233(2):187-97. doi: 10.1007/s00213-015-4099-3. Epub 2015 Oct 8.

PMID:
26446868
15.

Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.

Castells X, Karanović S, Ardin M, Tomić K, Xylinas E, Durand G, Villar S, Forey N, Le Calvez-Kelm F, Voegele C, Karlović K, Mišić M, Dittrich D, Dolgalev I, McKay J, Shariat SF, Sidorenko VS, Fernandes A, Heguy A, Dickman KG, Olivier M, Grollman AP, Jelaković B, Zavadil J.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1873-81. doi: 10.1158/1055-9965.EPI-15-0553. Epub 2015 Sep 17.

PMID:
26383547
16.

[Estimation of hospital costs of colorectal cancer in Catalonia (Spain)].

Corral J, Borràs JM, Chiarello P, García-Alzorriz E, Macià F, Reig A, Mateu de Antonio J, Castells X, Cots F.

Gac Sanit. 2015 Nov-Dec;29(6):437-44. doi: 10.1016/j.gaceta.2015.07.005. Epub 2015 Aug 28. Spanish.

17.

[Medical errors and the apology laws, do we need them?].

Giraldo P, Castells X.

Med Clin (Barc). 2015 Oct 21;145(8):341-3. doi: 10.1016/j.medcli.2015.04.019. Epub 2015 Jun 3. Spanish. No abstract available.

PMID:
26048542
18.

Robustness of equations that define molecular subtypes of glioblastoma tumors based on five transcripts measured by RT-PCR.

Castells X, Acebes JJ, Majós C, Boluda S, Julià-Sapé M, Candiota AP, Ariño J, Barceló A, Arús C.

OMICS. 2015 Jan;19(1):41-51. doi: 10.1089/omi.2014.0077.

19.

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.

Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, Vidal C, Natal C, Sánchez M, Saladié F, Ferrer J, Vernet M, Servitja S, Rodríguez-Arana A, Roman M, Espinàs JA, Sala M.

Breast Cancer Res Treat. 2015 Jan;149(1):237-44. doi: 10.1007/s10549-014-3208-z. Epub 2014 Dec 13.

20.

Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Jelaković B, Castells X, Tomić K, Ardin M, Karanović S, Zavadil J.

Int J Cancer. 2015 Jun 15;136(12):2967-72. doi: 10.1002/ijc.29338. Epub 2014 Dec 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk